or Try an Advanced Search...

    Drug Development Stocks List

    Symbol Grade Name % Change
    CLNN D Clene Inc. -0.41
    PTN D Palatin Technologies, Inc. 2.93
    ME D 23andMe Holding Co. -0.46
    RPRX D Royalty Pharma plc -1.22
    AZTA D Azenta, Inc. 1.62
    CSBR D Champions Oncology, Inc. 5.36
    AMPH F Amphastar Pharmaceuticals, Inc. -0.47
    ABCL F AbCellera Biologics Inc. 4.68
    NOTV F Inotiv, Inc. 2.64
    IMRX F Immuneering Corporation 5.13
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
    Related Stock Lists: Biotechnology Pharmaceutical Biopharmaceutical Health Sciences Pharmacology Biology Disease Life Sciences Medication Pharmaceutical Products Pharmaceutical Sciences Pharmacy Technology Solutions Active Pharmaceutical Ingredients Advanced Solid Tumors Antibodies Applied Genetics Bank Bioinformatics Biopharmaceutical Products

    Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 6.7
    PILL D Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 5.68
    ROYA A Tema Global Royalties ETF 5.59
    IHE C iShares U.S. Pharmaceutical ETF 5.25
    PINK C Simplify Health Care ETF 3.31
    View all Drug Development ETFs...
    Compare ETFs
    Compare PILL to PINK Compare XPH to IHE Compare XPH to ROYA

        Drug Development Stocks Recent News

        Date Stock Title
        May 3 AMPH Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
        May 2 RPRX Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
        May 2 PTN Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
        May 2 ABCL Insider Stock Buying Reaches US$1.61m On AbCellera Biologics
        May 2 NOTV Investors push Inotiv (NASDAQ:NOTV) 16% lower this week, company's increasing losses might be to blame
        May 2 AMPH Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
        May 2 PTN Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
        May 1 AZTA Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
        May 1 ABCL AbCellera partners with PE firms to develop antibody drugs, company creation
        May 1 ABCL Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
        May 1 AMPH Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
        May 1 ABCL AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
        May 1 CLNN IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
        Apr 30 AMPH Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
        Apr 30 AMPH Why Amphastar (AMPH) Could Beat Earnings Estimates Again
        Apr 30 ABCL Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
        Apr 30 PTN Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024
        Apr 29 NOTV Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
        Related Stock Lists: Biotechnology Pharmaceutical Biopharmaceutical Health Sciences Pharmacology Biology Disease Life Sciences Medication Pharmaceutical Products Pharmaceutical Sciences Pharmacy Technology Solutions Active Pharmaceutical Ingredients Advanced Solid Tumors Antibodies Applied Genetics Bank Bioinformatics Biopharmaceutical Products
        Drug Development

        Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

        Browse All Tags